Wegovy Injection Pen – 0.25 mg x 4 Doses (Semaglutide)

Wegovy Injection Pen contains semaglutide, a medication that mimics the activity of GLP-1 (glucagon-like peptide-1), a naturally occurring hormone involved in appetite regulation and blood sugar control. By activating GLP-1 receptors, semaglutide helps regulate hunger signals, slow gastric emptying, and improve insulin response.

These combined effects can help individuals feel satisfied with smaller portions and maintain better control over calorie intake. In addition to its role in weight management, semaglutide may also support improved glucose metabolism.

The 0.25 mg dose represents the first step in the Wegovy treatment schedule, typically used during the initial phase of therapy before gradually increasing to higher maintenance doses. Each pen contains four doses intended for once-weekly subcutaneous injection.

Supports weight management
Semaglutide helps regulate appetite and reduce hunger, which may support reduced calorie intake.

Helps control appetite signals
By acting on GLP-1 receptors in the brain, the medication helps promote a feeling of fullness after meals.

Gradual treatment initiation
The 0.25 mg dose is designed as a starting dose to help the body adapt to treatment.

Convenient weekly injection
The pre-filled pen allows for simple once-weekly administration at home.

Supports metabolic health
Improved appetite regulation and glucose metabolism may contribute to better long-term metabolic balance.

Wegovy (Semaglutide) Injection Pen – 0.25 mg is administered as a subcutaneous injection once per week.

General usage guidelines:

• Inject once weekly on the same day each week.

• The injection can be administered with or without food.

• Common injection sites include the abdomen, thigh, or upper arm.

• Rotate injection sites between doses to reduce skin irritation.

• Follow the dosage plan recommended by a healthcare professional.

The 0.25 mg dose is typically used during the first phase of treatment, after which the dosage may gradually increase to achieve optimal therapeutic results.

For best outcomes, treatment should be combined with healthy dietary habits, portion control, and regular physical activity.

Wegovy (Semaglutide) should be used under the supervision of a qualified healthcare professional.

Important precautions include:

• Common side effects may include nausea, vomiting, diarrhea, constipation, or decreased appetite.

• Inform your healthcare provider about any existing medical conditions before starting treatment.

• Individuals with a personal or family history of certain thyroid conditions should consult a doctor before using semaglutide.

• Do not use the medication if you are allergic to semaglutide or any components of the formulation.

• Store the injection pen according to manufacturer guidelines, typically refrigerated until use.

If severe side effects or allergic reactions occur, discontinue use and seek medical attention immediately.